This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming
- Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
- Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with 86Y for Quantitative PET of Carcinoma
- Immuno-PET Quantitation of de2-7 Epidermal Growth Factor Receptor Expression in Glioma Using 124I-IMP-R4-Labeled Antibody ch806
- Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
- Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
- The Promise of Immuno-PET in Radioimmunotherapy
- Enhancing Targeted Radiotherapy by Copper(II)diacetyl- bis(N4-methylthiosemicarbazone) Using 2-Deoxy-D-Glucose
- In Vivo Evaluation of Pretargeted 64Cu for Tumor Imaging and Therapy
- Copper-64-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for the Prevention of Tumor Growth at Wound Sites following Laparoscopic Surgery: Monitoring Therapy Response with microPET and Magnetic Resonance Imaging
- Immuno-PET of Human Colon Xenograft- Bearing BALB/c Nude Mice Using 124I-CDR-Grafted Humanized A33 Monoclonal Antibody
- Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy
- High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
- High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment